Patton Fund Management’s AbbVie ABBV Stock Holding History

Patton Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,759	Closed	-$1.04M	–	88
2026 Q1	$1.04M	Sell	4,759 -6,009	-56%	-$1.33M	0.18%	97
2025 Q4	$2.46M	Buy	10,768 +9,487	+741%	+$2.16M	0.33%	84
2025 Q3	$297K	Hold	1,281	–	–	0.05%	117
2025 Q2	$238K	Sell	1,281 -20,649	-94%	-$3.84M	0.05%	263
2025 Q1	$4.59M	Sell	21,930 -6,536	-23%	-$1.27M	1.11%	30
2024 Q4	$5.06M	Buy	+28,466	New	+$5.23M	0.99%	44
2023 Q2	–	Sell	-9,335	Closed	-$1.49M	–	82
2023 Q1	$1.49M	Sell	9,335 -5,035	-35%	-$770K	0.42%	62
2022 Q4	$2.32M	Buy	14,370 +50	+0.3%	+$7.67K	0.68%	52
2022 Q3	$1.92M	Sell	14,320 -1,270	-8%	-$182K	0.78%	38
2022 Q2	$2.39M	Buy	+15,590	New	+$2.38M	0.89%	22

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Patton Fund Management's ABBV Position: Q2 2026 in Review

Patton Fund Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 4,759 shares — an estimated $1.04M sold.

Patton Fund Management first reported a position in ABBV in Q2 2022 and held it in 10 quarters. The position peaked at $5.06M in Q4 2024. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Patton Fund Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Patton Fund Management sold 4,759 AbbVie shares in Q2 2026, an estimated $1.04M.
Patton Fund Management first reported a position in AbbVie in Q2 2022 and held it in 10 quarters.
Patton Fund Management's AbbVie position peaked at $5.06M in Q4 2024.
1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.